Differential clinical response to oestrogens after menopause

Area of Science:

• Endocrinology
• Pharmacology
• Women's Health

Background:

• Menopause is associated with various vasomotor, psychological, and physical symptoms.
• Hormone replacement therapy, particularly oestrogen therapy, is commonly prescribed to manage menopausal symptoms.

Purpose of the Study:

• To compare the efficacy of two different oestrogenic compounds, piperazine oestrone sulphate (Ogen) and conjugated equine oestrogens (Premarin), in alleviating postmenopausal symptoms.
• To investigate the differential effects of Ogen and Premarin on various bodily systems.

Main Methods:

• Analysis of vasomotor, psychological, and physical symptoms in 136 postmenopausal women.
• Comparative assessment of symptom response between women receiving Ogen and Premarin.

Main Results:

• Premarin (0.625 mg) demonstrated greater potency in inducing withdrawal bleeding compared to Ogen (1.25 mg).
• Ogen was more effective than Premarin in alleviating hot flushes and certain psychological symptoms.
• Observed differences in symptom response suggest distinct effects of the two oestrogenic compounds on different body parts.

Conclusions:

• The differing effects of Ogen and Premarin can be explained by their distinct impacts on various bodily tissues.
• A hypothesis involving the metabolism of oestrone to 2-hydroxyoestrone is proposed to explain these observed differences.
• Encouraging a more tailored selection of oestrogens based on specific postmenopausal symptoms is recommended for improved patient outcomes.